Showing results (801-810 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|February 6, 2014
Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastasesMay Hagiwara, Thomas E Delea, Karen ChungJournal of Medical Economics|April 14, 2017
Attributes of nuclear imaging centers impacting physician referrals for single-photon emission computed tomography myocardial perfusion imaging testsJunlong Li, Christy R Houle, James R Spalding, et al.Journal of Medical Economics|September 5, 2019
Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effectiveJ Maervoet, N Bossers, R P Borge, et al.Journal of Medical Economics|September 19, 2019
Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in ItalySteffen Haldrup, Annunziata Lapolla, Jens Gundgaard, et al.Journal of Medical Economics|August 3, 2019
Pacemaker complications and costs: a nationwide economic studyNicolas Clémenty, Jérôme Fernandes, Phuong Lien Carion, et al.Journal of Medical Economics|April 24, 2015
Cost-effectiveness analysis of quadrivalent influenza vaccination in at-risk adults and the elderly: an updated analysis in the U.KG Meier, M Gregg, B Poulsen NautrupJournal of Medical Economics|April 21, 2015
Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims databaseZ Zhao, Y Zhu, Y Fang, et al.Journal of Medical Economics|August 23, 2025
Projected hospitalization cost impact of the selective cytopheretic device in pediatric acute kidney injuryH David Humes, Nathan Kleinman, Jennifer Kammerer, et al.Journal of Medical Economics|September 4, 2025
Real world evidence on health care resource utilization and economic burden of arrhythmias in patients with COPDPierantonio Russo, Ramaa Nathan, Jason Poh, et al.Journal of Medical Economics|April 30, 2020
Economic burden in patients with ALK + non-small cell lung cancer, with or without brain metastases, receiving second-line anaplastic lymphoma kinase (ALK) inhibitorsHuamao M Lin, Xiaoyun Pan, Peijie Hou, et al.Pageof 241